Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Live Lab Tour 2012 to Visit Science Zones in Europe

Published: Monday, April 23, 2012
Last Updated: Monday, April 23, 2012
Bookmark and Share
The “Live Lab Tour” will be ready to roll on 15 May. This innovative concept brings latest Merck Millipore technologies to the workplace, with one-to-one planned meetings available at each site.

Merck Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany has announced the schedule for the Merck Millipore Live Lab Tour 2012 that will visit nine science parks and institutions in Europe starting in May.

The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is aLLT-visual-(3).gif novel way to bring information about new technologies right to the workplace. Keltoum Benchikh, Lab Water Head of Global Marketing-Communications, explains that the Live Lab Tour concept is part of a portfolio of marketing communications tools designed to present product information in the easiest, most accessible manner possible. “Live Lab visitors will discover our product offering in situ, and will get actual hands-on experience working with Merck Millipore equipment and other materials,” she says. “In addition, Merck Millipore experts will be present at each site to discuss best practices that will help visitors optimize protocols and improve their laboratory work flows,” she adds.

Three laboratories will be set up within the vehicle: a pharmaceutical lab, an academic research lab, and a food and beverages lab. All will be equipped with the Merck Millipore solutions required to perform actual experiments.

For visitors who would like to discuss their specific situations in more detail, special one-to-one sessions with Merck Millipore experts are available at each site from 10:00 am to 3:30 pm every day.

Schedule: Merck Millipore Live Lab Tour 2012
UK – London: 15 May, University College London
UK – London: 16 May, Imperial College
UK – Oxford: 17 May, Milton Science Park
UK – Newcastle: 21 May, Centre for Life
NL – Utrecht: 24 May, Universiteit Utrecht
BE – Liège: 29 May, Université de Liège
FR – Molsheim: 31 May, Merck Millipore
IT – Milan: 5 June, INFN (Italian National Institute of Nuclear Physics)


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Incoming CEO and President
Udit Batra, Ph.D. will be responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations.
Tuesday, April 15, 2014
Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients
Ensures current GMP and GDP requirements applied to pharmaceutical excipients through a recognized auditing and certification process.
Friday, August 02, 2013
Scientific News
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Preparing for Potential Zika Outbreaks
Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!